Growing community of inventors

Yongin-si, South Korea

Taehwan Kwak

Average Co-Inventor Count = 3.20

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Taehwan KwakSang-Ku Yoo (3 patents)Taehwan KwakMyunggyu Park (3 patents)Taehwan KwakIn Geun Jo (2 patents)Taehwan KwakKu Suk Kang (1 patent)Taehwan KwakSang Woo Yoo (1 patent)Taehwan KwakKu Suk Kang (0 patent)Taehwan KwakTaehwan Kwak (4 patents)Sang-Ku YooSang-Ku Yoo (6 patents)Myunggyu ParkMyunggyu Park (3 patents)In Geun JoIn Geun Jo (7 patents)Ku Suk KangKu Suk Kang (1 patent)Sang Woo YooSang Woo Yoo (1 patent)Ku Suk KangKu Suk Kang (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Kt & G Co., Ltd. (4 from 5 patents)

2. Md Bioalpha Co., Ltd. (3 from 5 patents)

3. Mazence Inc. (1 from 1 patent)


4 patents:

1. 9066922 - Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases

2. 8466141 - Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases

3. 8404869 - Phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome

4. 8029832 - Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/10/2025
Loading…